Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

N/A by N/A is licensed under N/A N/A
The pharmaceutical industry is pushing back against Governor Cuomo's prescription drug price control proposal, arguing that it would lead to cuts in research. And they are pointing the finger at insurance companies and companies known as pharmacy benefit managers for the high costs paid by patients. Peter Pitts is a former FDA Associate Commissioner for External Relations and is now President of the Center for Medicine in the Public Interest.

 
Article Photo Credit: N/A by N/A is licensed under N/A N/A
Sign Up for Our Email Newsletter

RECENT NEWS

AARP's Stop Rx Greed Campaign Should Focus on AARP's Rx Greed

AARP's Stop Rx Greed Campaign Should Focus on AARP's Rx Greed

...  Read more

FDA is smashing the status quo for regulatory science

FDA is smashing the status quo for regulatory science

The most potent way the FDA can enable innovation is by being a partner in advancing new approaches to both drug developm...  Read more

True Cost of Socialized Medicine & the Right Way to Hold Down the Cost of Healthcare

True Cost of Socialized Medicine & the Right Way to Hold Down the Cost of Healthcare

...  Read more

DRUGWONKS BLOG